Graeme J. Sills - Concepedia

Author

Graeme J. Sills

Also Known As

Belcastro Vicenzo, Cécile Cieuta-Walti, G SILLS, G Sills, G. E. Sills, G. J. Sills, G.J Sills, G.J. Sills, GRAEME J. SILLS, Graeme J Sills

167

Publications

9.6K

Citations

H-Index

117

Concepts

All Affiliations

Western Infirmary University of Liverpool University College London Walton Centre University Medical Center Utrecht

About

Graeme J. Sills is an author at Western Infirmary specializing in medicine, neurology, and neuroscience.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	27	36	3K
2	Social Sciences	18	22	1.4K
3	Public Health	2	2	68
4	Health Sciences	1	1	45
5	Natural Sciences	1	1	493

Graeme J. Sills

Publications

6.3K

Citations

H-Index

Page 1

	Year	Citations
HLA-A*3101 and Carbamazepine-Induced Hypersensitivity Reactions in Europeans Mark McCormack, Ana Alfirevic, Stéphane Bourgeois, New England Journal of Medicine	2011	899
Predictors of pharmacoresistant epilepsy Nikolas Hitiris, Rajiv Mohanraj, John Norrie, Epilepsy Research NeurophysiologyMedicinePsychopharmacologyNeuropharmacologyPharmacotherapy	2007	509
Genome-wide mega-analysis identifies 16 loci and highlights diverse biological mechanisms in the common epilepsies Bassel Abou‐Khalil, Pauls Auce, Andreja Avberšek, Nature Communications Epilepsy TherapiesGeneticsGenetic EpidemiologyMolecular GeneticsMonogenic Epilepsy Genes	2018	493
Ultra-Rare Genetic Variation in the Epilepsies: A Whole-Exome Sequencing Study of 17,606 Individuals Yen‐Chen Anne Feng, Daniel P. Howrigan, Liam Abbott, The American Journal of Human Genetics Allelic VariantUltra-rare Genetic VariationWhole-exome Sequencing StudyGeneticsGenetic Disorder	2019	298
Ultra-rare genetic variation in common epilepsies: a case-control sequencing study Andrew S. Allen, Susannah T. Bellows, Samuel F. Berkovic, The Lancet Neurology Allelic VariantUltra-rare Genetic VariationMedicineGeneticsGenetic Disorder	2017	232
Prevalence of neurologic autoantibodies in cohorts of patients with new and established epilepsy Tanja Brenner, Graeme J. Sills, Yvonne Hart, Epilepsia	2013	228
The SANAD II study of the effectiveness and cost-effectiveness of valproate versus levetiracetam for newly diagnosed generalised and unclassifiable epilepsy: an open-label, non-inferiority, multicentre, phase 4, randomised controlled trial Anthony G Marson, Girvan Burnside, Richard Appleton, The Lancet	2021	202
Lack of Association between the C3435T Polymorphism in the Human Multidrug Resistance (<i>MDR1</i>) Gene and Response to Antiepileptic Drug Treatment Graeme J. Sills, Rajiv Mohanraj, Elaine Butler, Epilepsia	2005	193
The SANAD II study of the effectiveness and cost-effectiveness of levetiracetam, zonisamide, or lamotrigine for newly diagnosed focal epilepsy: an open-label, non-inferiority, multicentre, phase 4, randomised controlled trial Anthony G Marson, Girvan Burnside, Richard Appleton, The Lancet	2021	183
Bone density and antiepileptic drugs: a case-controlled study Linda J. Stephen, A. R. McLellan, Joyce Harrison, Seizure Bone DiseaseBone HealthAntiepileptic DrugsMedicineOsteoarthritis	1999	159

Page 1